Issue Archive
September 2009 | Volume 8 | Issue 9
Editorials
The Management of Psoriasis in the Age of Biologics: Clinical Update 2009
This activity is supported by an educational donation provided by Astellas Pharma US Inc. and Amgen and Wyeth Pharmaceuticals....
Read More
Original Articles
Washington Update
Do Topical Retinoids Cause Acne to "Flare"?
Background: Guidelines support this use of topical retinoids as a fundamental part of acne treatment regimens. However, existing dogma holds that topical retinoids may initially worsen acne.
<...
Read MoreClinical Role and Application of Superficial Chemical Peels in Today's Practice
Chemical peeling is a popular, relatively inexpensive, and generally safe method to refresh and rejuvenate skin. This review focuses on superficial chemical peels and their use in routine clinical pr...
Read MoreComparing a Novel Solubilized Benzoyl Peroxide Gel With Benzoyl Peroxide/Clindamycin: Final Data From a Multicenter, Investigator-Blind, Randomized Study
Introduction: A solubilized 5% BPO gel has been developed to enhance the bioavailability, follicular penetration, and efficacy of BPO.
Methods: Sixty-five patients with moder...
Read MoreLaser Treatment of Dark Skin: A Review and Update
Of the estimated 11.7 million cosmetic surgical and nonsurgical procedures performed in the United States (U.S.) in 2007, 22% were performed on racial and ethnic minorities. Laser and light treatment...
Read MoreTwo-Center Canadian Report on the Safety and Effectiveness of Evolence Breeze
Evolence Breeze, a new less viscous form of the ribose crosslinked Israeli porcine collagen Evolence, was approved for use in Canada as a cosmetic soft tissue augmenting agent on July 14, 2006.
Read MoreA Randomized Controlled Trial of a Low-Dose Combined Oral ContraceptiveContaining 3 mg Drospirenone Plus 20 μg Ethinylestradiol in the Treatment of AcneVulgaris: Lesion Counts, Investigator Ratings and Subject Self-Assessment
Objective: To assess the efficacy of a combined oral contraceptive (COC) containing 3 mg drospirenone (drsp) plus 20 μg ethinylestradiol (EE) administered in 24 days of active treatment followed...
Read MoreUse of Clofazimine in Dermatology
Clofazimine is the riminophenazine dye that, due to its antibacterial and anti-inflammatory properties, has been used for several diseases. This article reviews all major characteristics and uses rel...
Read MoreUse of Eye Shields and Eye Lubricants Among Oculoplastic and Mohs Surgeons:A Survey
Background: Eye shields and lubricants are recommended for use in the eye during periorbital surgery to prevent injury to the globe. Nonetheless, data regarding their use is sparse, and no study to d...
Read MoreBenefits of Using a Hydroquinone/Tretinoin Skin Care System in PatientsUndergoing Intense Pulsed Light Therapy for Photorejuvenation:A Placebo-Controlled Study
A hydroquinone/tretinoin (HQ/tret) skin care system designed for use with non-surgical facial rejuvenation procedures has recently become available. In this observer-masked study, 36 patients with mod...
Read MoreNews, Views and Reviews
Pipeline Previews
Clinical Trial Review
Case Reports
Concurrent Antiphospholipid Syndrome and Sutaneous Sarcoidosis Due toInterferon Alfa and Ribavirin Treatment for Hepatitis C
Autoimmune phenomena are common in both hepatitis C infection and interferon alfa treatment; however, the development of antiphospholipid syndrome is rare. This article reports the case of a patient ...
Read MoreTwo Cases of Chronic Atopic Dermatitis Treated With Soluble Tumor NecrosisFactor Receptor Therapy
Atopic dermatitis (AD) is a chronic inflammatory disease that is mediated by cytokines. In patients with AD, the use of tumor necrosis factor (TNF) antagonists has had unpredictable results. Clinical...
Read More
